Encouraging Antibiotics Research Biotechs Have Plenty to GAIN
The FDA wants to hear from industry and other interested parties on what should constitute a "qualifying pathogen" that could trigger a range of incentives designed to encourage companies to develop new antibiotics targeting these designated pathogens.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST